by BetaLife | Jul 14, 2026 | Press Release
BetaLife Advances A Step Closer to First-In-Human Trials with Clinical Partnership Strengthened and GMP Manufacturing Hub Established in China Singapore and Xiamen, China — 14 July 2026 — BetaLife has reached a major milestone in its China expansion with the official...
by BetaLife | Mar 3, 2025 | Press Release
BetaLife Pte Ltd has appointed Dr Natasha Hui Jin Ng (吴荟瑾博士) as Chief Scientific Officer (CSO) and acting Chief Executive Officer (CEO) with effect from 3 March 2025. Natasha brings to BetaLife deep scientific expertise and entrepreneurial experience. She has over 12...
by BetaLife | Mar 22, 2023 | Press Release
BetaLife has acquired the rights to human iPSC technology and cell lines from A*STAR BetaLife and A*STAR sign research collaboration agreement to jointly develop a platform for generating islet cells from human iPSCs with the potential of cell replacement therapy for...
